AKT1 and multiple sclerosis: Multiple studies indicated that SRC regulated the PI3K-AKT pathway in inflammation-related diseases such as multiple sclerosis (MS), Grave’s Disease (GD), and in the neutrophil extracellular traps (NET) formation [42,43,44].